Erika L. Nurmi

3.3k total citations · 1 hit paper
31 papers, 748 citations indexed

About

Erika L. Nurmi is a scholar working on Cognitive Neuroscience, Molecular Biology and Genetics. According to data from OpenAlex, Erika L. Nurmi has authored 31 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cognitive Neuroscience, 8 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Erika L. Nurmi's work include Diet and metabolism studies (5 papers), Child and Adolescent Psychosocial and Emotional Development (5 papers) and Genetics and Neurodevelopmental Disorders (5 papers). Erika L. Nurmi is often cited by papers focused on Diet and metabolism studies (5 papers), Child and Adolescent Psychosocial and Emotional Development (5 papers) and Genetics and Neurodevelopmental Disorders (5 papers). Erika L. Nurmi collaborates with scholars based in United States, Canada and Japan. Erika L. Nurmi's co-authors include James T. McCracken, Edythe D. London, Jessica L. Borelli, Kelly E. Caudle, J. Steven Leeder, Teri E. Klein, Jacob T. Brown, José de León, Andrea Gaedigk and Daniel Mueller and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Erika L. Nurmi

29 papers receiving 735 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler Looking for Clarity in the Haze of the Pandemic

2022 107 citations Yong Huang, Melissa D. Pinto et al. Clinical Nursing Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erika L. Nurmi United States	16	181	174	132	109	105	31	748
Peter N. van Harten Netherlands	17	436 2.4×	173 1.0×	106 0.8×	59 0.5×	78 0.7×	48	858
Matthew Macaluso United States	14	209 1.2×	142 0.8×	43 0.3×	203 1.9×	133 1.3×	64	902
Stefan Unterecker Germany	14	372 2.1×	101 0.6×	97 0.7×	93 0.9×	64 0.6×	71	818
Mei‐Chun Hsiao Taiwan	18	203 1.1×	148 0.9×	51 0.4×	68 0.6×	94 0.9×	37	766
Eva J. Brandl Germany	20	368 2.0×	197 1.1×	140 1.1×	199 1.8×	115 1.1×	56	1.1k
Siow‐Ann Chong Singapore	23	795 4.4×	201 1.2×	82 0.6×	75 0.7×	101 1.0×	43	1.1k
P. Roberto Bakker Netherlands	15	355 2.0×	44 0.3×	76 0.6×	61 0.6×	88 0.8×	29	584
Claudia Mehler‐Wex Germany	21	609 3.4×	219 1.3×	143 1.1×	35 0.3×	111 1.1×	50	1.1k
Judith C. Kando United States	15	741 4.1×	135 0.8×	71 0.5×	133 1.2×	99 0.9×	40	1.2k
Emily E. Hartwell United States	19	69 0.4×	200 1.1×	137 1.0×	21 0.2×	223 2.1×	50	1.0k

Countries citing papers authored by Erika L. Nurmi

Since Specialization

Citations

This map shows the geographic impact of Erika L. Nurmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika L. Nurmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika L. Nurmi more than expected).

Fields of papers citing papers by Erika L. Nurmi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika L. Nurmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika L. Nurmi. The network helps show where Erika L. Nurmi may publish in the future.

Co-authorship network of co-authors of Erika L. Nurmi

This figure shows the co-authorship network connecting the top 25 collaborators of Erika L. Nurmi. A scholar is included among the top collaborators of Erika L. Nurmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika L. Nurmi. Erika L. Nurmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Besterman, Aaron D., Lynn E. DeLisi, Dorothy E. Grice, et al.. (2025). Psychiatric Genetics in Clinical Practice: Essential Knowledge for Mental Health Professionals. American Journal of Psychiatry. 182(8). 728–741.

Fitzpatrick, Sarah E., Erika L. Nurmi, Thomas Fernandez, et al.. (2024). Review: Child Psychiatry in the Era of Genomics: The Promise of Translational Genetics Research for the Clinic. PubMed. 3(2). 157–170. 2 indexed citations

Nurmi, Erika L., Harriet de Wit, Abraham A. Palmer, et al.. (2023). Polygenic contributions to performance on the Balloon Analogue Risk Task. Molecular Psychiatry. 28(8). 3524–3530. 4 indexed citations

Spivak, Norman M., Collin M. Price, Margaret G. Distler, et al.. (2022). Microbiome in Anxiety and Other Psychiatric Disorders. Medical Clinics of North America. 107(1). 73–83. 2 indexed citations

Huang, Yong, Melissa D. Pinto, Jessica L. Borelli, et al.. (2022). COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler Looking for Clarity in the Haze of the Pandemic. Clinical Nursing Research. 31(8). 1390–1398. 107 indexed citations breakdown →

Nurmi, Erika L., et al.. (2021). The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children. Frontiers in Psychiatry. 12. 623681–623681. 54 indexed citations

Nurmi, Erika L.. (2020). Panacea, placebo or poison? Genetically guided treatment for depression. Brazilian Journal of Psychiatry. 42(2). 118–119. 1 indexed citations

London, Edythe D., Kyoji Okita, Arthur L. Brody, et al.. (2020). No significant elevation of translocator protein binding in the brains of recently abstinent methamphetamine users. Drug and Alcohol Dependence. 213. 108104–108104. 12 indexed citations

Brown, Jacob T., Jeffrey R. Bishop, Katrin Sangkuhl, et al.. (2019). Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy. Clinical Pharmacology & Therapeutics. 106(1). 94–102. 136 indexed citations

10.

Maciukiewicz, Małgorzata, Arun K. Tiwari, Clement C. Zai, et al.. (2019). Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans. Schizophrenia Research. 212. 204–212. 17 indexed citations

11.

Borelli, Jessica L., et al.. (2018). Interaction between the Opioid Receptor OPRM1 Gene and Mother-Child Language Style Matching Prospectively Predicts Children’s Separation Anxiety Disorder Symptoms. Research in Developmental Disabilities. 82. 120–131. 12 indexed citations

12.

Borelli, Jessica L., et al.. (2018). Parental overcontrol x OPRM1 genotype interaction predicts school-aged children’s sympathetic nervous system activation in response to performance challenge. Research in Developmental Disabilities. 82. 39–52. 10 indexed citations

13.

Dean, Andy C., Erika L. Nurmi, Scott J. Moeller, et al.. (2018). No effect of attentional bias modification training in methamphetamine users receiving residential treatment. Psychopharmacology. 236(2). 709–721. 16 indexed citations

14.

Brody, Arthur L., Carl K. Hoh, David R. Vera, et al.. (2018). Effect of overnight smoking abstinence on a marker for microglial activation: a [11C]DAA1106 positron emission tomography study. Psychopharmacology. 235(12). 3525–3534. 26 indexed citations

15.

O’Neill, Joseph, John Piacentini, Susanna Chang, et al.. (2017). Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial. Neuropsychopharmacology. 42(12). 2414–2422. 36 indexed citations

16.

Kohno, Milky, et al.. (2015). Functional Genetic Variation in Dopamine Signaling Moderates Prefrontal Cortical Activity During Risky Decision Making. Neuropsychopharmacology. 41(3). 695–703. 27 indexed citations

17.

Brandl, Eva J., Arun K. Tiwari, Clement C. Zai, et al.. (2015). Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample. The Pharmacogenomics Journal. 16(4). 352–356. 36 indexed citations

18.

Davis, Michael C., William P. Horan, Erika L. Nurmi, et al.. (2014). Associations between oxytocin receptor genotypes and social cognitive performance in individuals with schizophrenia. Schizophrenia Research. 159(2-3). 353–357. 30 indexed citations

19.

McCracken, James T., David J. Posey, M. G. Aman, et al.. (2013). Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders. The Pharmacogenomics Journal. 14(3). 295–302. 32 indexed citations

20.

Nurmi, Erika L., Fiona Whelan, M. G. Aman, et al.. (2013). Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies. Translational Psychiatry. 3(6). e274–e274. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact